GlassScriptPhysician profile
Raman L Mitra
NPI 1528062221
$49,958.85
in general payments reported to CMS, 2019-2025
24 companies · $1,763 in 2025
The $1,763 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $28K · 2020: $4,237 · 2021: $3,738 · 2022: $5,102 · 2023: $2,408 · 2024: $4,572 · 2025: $1,763.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,396 · Consulting Fee: $3,000 · Travel and Lodging: $2,347.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,395.78 |
| Consulting Fee | $3,000.00 |
| Travel and Lodging | $2,346.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biosense Webster, INC. | $22,240.39 | 2019-2025 | Carto 3, Qdot Micro Catheter |
| Janssen Pharmaceuticals, INC | $15,308.67 | 2019-2024 | Xarelto |
| Medtronic, INC. | $4,579.90 | 2021-2025 | Symplicity G3, Selectsecure, Cobalt Dr Mri Surescan |
| Abbott Laboratories | $2,719.73 | 2019-2025 | Aveir, Ensite Precision, Perclose Prostyle |
| Philips North America LLC | $2,000.00 | 2021 | |
| Boston Scientific Corporation | $1,360.62 | 2019-2025 | Emblem Mri S-Icd, Watchman Flx |
| Medtronic Vascular, INC. | $410.02 | 2019-2020 | |
| Cvrx, INC. | $244.26 | 2022-2024 | Barostim Neo System |
| Impulse Dynamics (USA) INC. | $206.16 | 2020-2021 | |
| Siemens Medical Solutions USA, INC. | $202.15 | 2019-2020 | |
| Stereotaxis INC | $180.66 | 2022-2023 | Niobe |
| Novartis Pharmaceuticals Corporation | $175.06 | 2019 | |
| Atricure, INC. | $66.37 | 2023 | |
| Cordis US Corp. | $49.50 | 2025 | Mynx Control Venous |
| Covidien LP | $46.15 | 2019 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $33.51 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $29.64 | 2019-2025 | Lifevest |
| Edwards Lifesciences Corporation | $20.24 | 2021 | |
| Cardiva Medical, INC. | $17.13 | 2022 | |
| Ge Healthcare | $15.14 | 2019 | |
| Davol INC. | $14.87 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $13.58 | 2019 | |
| Sanofi-Aventis U.S. LLC | $13.31 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $11.79 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Raman Mitra listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.